CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.48%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.8B
AUM Growth
+$630M
(+4.4%)
Cap. Flow
-$386M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
926
New
50
Increased
255
Reduced
457
Closed
57
Top Buys
| 1 |
Mercado Libre
MELI
|
+$41.1M |
| 2 |
Darling Ingredients
DAR
|
+$37M |
| 3 |
Johnson & Johnson
JNJ
|
+$34.5M |
| 4 |
Veru
VERU
|
+$34M |
| 5 |
MetLife
MET
|
+$31.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$46.7M |
| 2 |
Nike
NKE
|
+$42.5M |
| 3 |
Illinois Tool Works
ITW
|
+$37M |
| 4 |
Gilead Sciences
GILD
|
+$32.3M |
| 5 |
Merck
MRK
|
+$30.3M |
Sector Composition
| 1 | Healthcare | 33.31% |
| 2 | Technology | 22.85% |
| 3 | Financials | 10.04% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Avery Dennison
AVY
$13.1B
| $8.54M | 0.06% |
47,158
+19,510
| +71% | +$3.53M |
|
302
Truist Financial
TFC
$59.3B
| $8.51M | 0.06% |
197,835
-10,606
| -5% | -$456K |
|
303
Amicus Therapeutics
FOLD
$2.46B
| $8.47M | 0.06% |
693,879
+25,000
| +4% | +$305K |
|
304
Micron Technology
MU
$147B
| $8.46M | 0.06% |
169,237
-265,458
| -61% | -$13.3M |
|
305
Bank of Montreal
BMO
$90.9B
| $8.39M | 0.06% |
92,712
-90,317
| -49% | -$8.18M |
|
|
RXDX
306
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $8.25M | 0.06% |
75,000
-15,000
| -17% | -$1.65M |
|
307
Union Pacific
UNP
$129B
| $8.12M | 0.05% |
39,230
-4,765
| -11% | -$987K |
|
308
Zimmer Biomet
ZBH
$20.7B
| $7.98M | 0.05% |
62,591
-16,047
| -20% | -$2.05M |
|
309
Fiserv
FI
$73.5B
| $7.78M | 0.05% |
76,989
-5,208
| -6% | -$526K |
|
310
Sunrun
RUN
$3.9B
| $7.76M | 0.05% |
323,110
+32,754
| +11% | +$787K |
|
311
Blink Charging
BLNK
$126M
| $7.76M | 0.05% |
707,343
+240,842
| +52% | +$2.64M |
|
312
PTC Therapeutics
PTCT
$4.52B
| $7.73M | 0.05% |
202,652
| – | – |
|
313
Nuvalent
NUVL
$5.76B
| $7.7M | 0.05% |
+258,649
| New | +$7.7M |
|
314
AT&T
T
$207B
| $7.67M | 0.05% |
416,511
-27,041
| -6% | -$498K |
|
315
Crown Castle
CCI
$40.9B
| $7.52M | 0.05% |
55,463
-9,755
| -15% | -$1.32M |
|
316
Blackrock
BLK
$171B
| $7.49M | 0.05% |
10,577
+576
| +6% | +$408K |
|
317
Travelers Companies
TRV
$61.8B
| $7.43M | 0.05% |
39,631
-5,267
| -12% | -$987K |
|
318
GE Aerospace
GE
$293B
| $7.36M | 0.05% |
141,062
-16,128
| -10% | -$842K |
|
319
Hershey
HSY
$38B
| $7.35M | 0.05% |
31,720
-1,932
| -6% | -$447K |
|
320
Dyne Therapeutics
DYN
$1.89B
| $7.34M | 0.05% |
633,624
+220,000
| +53% | +$2.55M |
|
321
Oracle
ORCL
$670B
| $7.31M | 0.05% |
89,408
-10,313
| -10% | -$843K |
|
322
Lam Research
LRCX
$133B
| $7.3M | 0.05% |
173,690
-24,410
| -12% | -$1.03M |
|
323
Sempra
SRE
$51.8B
| $7.19M | 0.05% |
93,072
-3,024
| -3% | -$234K |
|
324
Planet Fitness
PLNT
$8.75B
| $7.18M | 0.05% |
91,069
+1,721
| +2% | +$136K |
|
|
EVOP
325
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $7.11M | 0.05% |
210,156
+172,479
| +458% | +$5.84M |
|